tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SDGR Stock Latest News

Schrodinger price target lowered to $28 from $30 at KeyBanc
The FlySchrodinger price target lowered to $28 from $30 at KeyBanc
19h ago
SDGR
Hold Rating on Schrodinger Amid Uncertainty in Software Growth and Promising Drug Pipeline
PremiumRatings
Hold Rating on Schrodinger Amid Uncertainty in Software Growth and Promising Drug Pipeline
7d ago
SDGR
Schrodinger initiated with a Neutral at Goldman Sachs
PremiumThe Fly
Schrodinger initiated with a Neutral at Goldman Sachs
9d ago
SDGR
Schrodinger Announces CFO Geoffrey Porges’ Departure
PremiumCompany Announcements
Schrodinger Announces CFO Geoffrey Porges’ Departure
1M ago
8K
SDGR
Private Markets: Anthropic raises $13B Series F at $183B post-money valuation
PremiumThe Fly
Private Markets: Anthropic raises $13B Series F at $183B post-money valuation
1M ago
AI
GS
Schrodinger downgraded to Neutral from Buy at Citi
PremiumThe FlySchrodinger downgraded to Neutral from Buy at Citi
2M ago
SDGR
Schrodinger’s Hold Rating: Challenges in Drug Pipeline and Software Growth Amid Macroeconomic Headwinds
Premium
Ratings
Schrodinger’s Hold Rating: Challenges in Drug Pipeline and Software Growth Amid Macroeconomic Headwinds
2M ago
SDGR
Schrodinger discontinues SGR-2921 clinical development program
Premium
The Fly
Schrodinger discontinues SGR-2921 clinical development program
2M ago
SDGR
Schrodinger initiated with an Overweight at Barclays
PremiumThe Fly
Schrodinger initiated with an Overweight at Barclays
2M ago
SDGR
Schrodinger’s Strong Financial Performance and Promising Pipeline Developments Justify Buy Rating
PremiumRatings
Schrodinger’s Strong Financial Performance and Promising Pipeline Developments Justify Buy Rating
2M ago
SDGR
Schrodinger’s Strategic Growth and Financial Stability: Buy Rating Affirmed
PremiumRatings
Schrodinger’s Strategic Growth and Financial Stability: Buy Rating Affirmed
2M ago
SDGR
Schrodinger, Inc. Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Schrodinger, Inc. Earnings Call: Growth Amid Challenges
2M ago
SDGR
Schrödinger, Inc. Reports Strong Q2 2025 Results
PremiumCompany AnnouncementsSchrödinger, Inc. Reports Strong Q2 2025 Results
2M ago
SDGR
Schrodinger reports Q2 EPS (59c), one estimate (64c)
Premium
The Fly
Schrodinger reports Q2 EPS (59c), one estimate (64c)
2M ago
SDGR
Schrodinger sees Software revenue growth of 10%-15%
Premium
The Fly
Schrodinger sees Software revenue growth of 10%-15%
2M ago
SDGR
Meta upgraded, PNC Financial downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Meta upgraded, PNC Financial downgraded: Wall Street’s top analyst calls
3M ago
FDX
IMO
Schrodinger assumed with an Equal Weight at Morgan Stanley
PremiumThe Fly
Schrodinger assumed with an Equal Weight at Morgan Stanley
3M ago
SDGR
Schrodinger Announces Board Elections and Approvals
PremiumCompany Announcements
Schrodinger Announces Board Elections and Approvals
4M ago
8K
SDGR
Positive Outlook for Schrödinger: Promising Phase 1 Data and Strategic Growth Initiatives Support Buy Rating
PremiumRatings
Positive Outlook for Schrödinger: Promising Phase 1 Data and Strategic Growth Initiatives Support Buy Rating
4M ago
SDGR
Schrodinger’s Promising Clinical Data Offset by Market Concerns: Hold Rating Maintained
PremiumRatingsSchrodinger’s Promising Clinical Data Offset by Market Concerns: Hold Rating Maintained
4M ago
SDGR
Optimistic Buy Rating for Schrodinger Amid Promising Drug Developments and Strategic Growth Potential
Premium
Ratings
Optimistic Buy Rating for Schrodinger Amid Promising Drug Developments and Strategic Growth Potential
4M ago
SDGR
Schrodinger announces initial clinical data from SGR-1505 study
Premium
The Fly
Schrodinger announces initial clinical data from SGR-1505 study
4M ago
SDGR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >